Northwire Canada EditionFriday, July 10, 2026
Northwire
S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0% S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0%
Production / Operations

Vext receives licence for seventh dispensary in Ohio

VEXT · Price

Executive Summary

  • Vext Science Inc. has been granted a dual-use provisional license by the Ohio Division of Cannabis Control for its seventh retail dispensary location in Columbus, Ohio.
  • The new facility will be located on the west side of Columbus near the I-270 and Roberts Road interchange, serving a growing residential area with limited nearby competition.
  • Construction is scheduled to begin in March, with operations expected to commence in the fourth quarter of 2026, subject to final regulatory approvals.

Key Details

  • License Status: Granted a dual-use provisional license for medical and adult-use retail sales, confirming compliance with all applicable zoning and statutory setback requirements.
  • Location: West side of Columbus, near the I-270 and Roberts Road interchange; adjacent to Hilliard; second location in Columbus.
  • Capital Costs: Total estimated capital costs are approximately $3.3 million, covering land acquisition and construction.
  • Construction Timeline: Construction agreement executed; buildout includes a stand-alone facility with a drive-through; construction begins in March; operations expected in Q4 2026.
  • Strategic Context: This marks the seventh Ohio dispensary. Combined with the sixth location in Fairfield (expected to open Q2 2026), Vext aims to reach the state maximum of eight dispensaries.
  • Operational Scope: Upon completion, the company will operate eight dispensaries supported by its Tier I cultivation and manufacturing facilities.

Notable Quotes

  • "Securing our seventh Ohio dispensary licence is another important step in our disciplined retail expansion... With construction under way and our remaining Ohio projects advancing, we have a clear line of sight to the state's eight-store cap and remain committed to disciplined capital allocation and sustainable shareholder value creation." — Eric Offenberger, CEO
Read the original news release →

More from Vext Science Inc